TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -20.0% | 16 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | -56.5% | 16 | -42.9% | 0.00% | – |
| Q1 2023 | $23 | +4.5% | 28 | 0.0% | 0.00% | – |
| Q4 2022 | $22 | – | 28 | -30.0% | 0.00% | – |
| Q3 2022 | $0 | – | 40 | +150.0% | 0.00% | – |
| Q2 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 16 | -100.0% | 0.00% | – |
| Q3 2021 | $169,000 | -59.1% | 90,483 | -43.0% | 0.00% | – |
| Q2 2021 | $413,000 | – | 158,790 | +1058500.0% | 0.00% | – |
| Q1 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $22 | 0.00% |
| Renaissance Technologies | 36,510 | $35,000 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |